Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-05-14
2008-03-11
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S047000, C514S224200
Reexamination Certificate
active
07342009
ABSTRACT:
Compounds of formula I:inhibit the processing of APP by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease.
REFERENCES:
patent: 2006/0281737 (2006-12-01), Dinnell
patent: WO 00/50391 (2000-08-01), None
patent: WO 01/70677 (2001-09-01), None
patent: WO 02/36555 (2002-05-01), None
patent: WO 02/081435 (2002-10-01), None
patent: WO-02/081435 (2002-10-01), None
patent: WO 03/055850 (2003-07-01), None
patent: WO 2004/101538 (2004-11-01), None
Dinnell Kevin
Harrison Timothy
Nadin Alan John
Owens Andrew Pate
Shaw Duncan Edward
Coppins Janet L
Krovatin William
Merck & Co. , Inc.
Saeed Kamal A.
Todaro John C.
LandOfFree
Cyclic sulfonamides for inhibition of gamma-secretase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic sulfonamides for inhibition of gamma-secretase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic sulfonamides for inhibition of gamma-secretase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3964693